한빛사논문 | BRIC

박희열 님의 논문 목록

명지병원 가정의학과

CV File 133 kb

Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
- JAMA Netw. Open, 2023 Aug 1;6(8):e2329568 | doi:10.1001/jamanetworkopen.2023.29568
- 2023-08
- 의약학
- 한빛사논문
Letter to the Editor: Is lifestyle modification effective for individuals with high fibrosis-4 index without an additional 2nd tier test?
- Hepatology, 2023 Jun 13 | doi: 10.1097/HEP.0000000000000512
- 2023-06
- 의약학
- 한빛사논문
Nomenclature Dilemma of Metabolic Associated Fatty Liver Disease (MAFLD): Considerable Proportions of MAFLD Are Metabolic Healthy
- Clin. Gastroenterol. Hepatol., Available online 30 April 2022 | https://doi.org/10.1016/j.cgh.2022.04.012
- 2022-04
- 의약학
- 한빛사논문
[Letter to the Editor]Do we need a new cut-off for FIB-4 in the metabolic dysfunction-associated fatty liver disease era?
- J. Hepatol., Available online 9 June 2021 | https://doi.org/10.1016/j.jhep.2021.05.035
- 2021-06
- 의약학
- 한빛사논문
[Letter]Diabetes is the strongest risk factor of hepatic fibrosis in lean patients with non-alcoholic fatty liver disease
- Gut, First published June 14, 2021 | http://dx.doi.org/10.1136/gutjnl-2021-325102
- 2021-06
- 의약학
- 한빛사논문
Multifunctional Nanoparticles for Photothermally Controlled Drug Delivery and Magnetic Resonance Imaging Enhancement
- Small, Volume 4, Issue 2, pages 192-196, February 1, 2008 | DOI: 10.1002/smll.200700807
- 2008-02
- 바이오·의료융합
- 상위피인용논문

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기